Lisa M. Stempak

460 total citations
16 papers, 134 citations indexed

About

Lisa M. Stempak is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lisa M. Stempak has authored 16 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lisa M. Stempak's work include Streptococcal Infections and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Lisa M. Stempak is often cited by papers focused on Streptococcal Infections and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Lisa M. Stempak collaborates with scholars based in United States and Australia. Lisa M. Stempak's co-authors include Robert W. Maitta, Gary W. Procop, Robert Wyllie, Hong Hong, Wenbin Xiao, Sandra S. Richter, Sherilynn Vogel, Linda M. Sandhaus, Mary E. Marquart and Rana E. El Feghaly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Lisa M. Stempak

15 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa M. Stempak United States	8	55	47	35	30	22	16	134
Chiara Oltolini Italy	8	75 1.4×	68 1.4×	26 0.7×	50 1.7×	22 1.0×	20	184
Guillermo Benchetrit Argentina	8	36 0.7×	49 1.0×	15 0.4×	28 0.9×	18 0.8×	12	125
Laura Cursi Italy	8	50 0.9×	52 1.1×	17 0.5×	10 0.3×	20 0.9×	21	181
Megha Brijwal India	8	41 0.7×	57 1.2×	12 0.3×	8 0.3×	13 0.6×	23	140
Severien Meyers Belgium	7	128 2.3×	105 2.2×	21 0.6×	16 0.5×	67 3.0×	8	253
V. Manceron France	6	71 1.3×	113 2.4×	11 0.3×	112 3.7×	11 0.5×	7	227
Jehad Abdalla United States	7	40 0.7×	60 1.3×	27 0.8×	4 0.1×	8 0.4×	14	163
Olga Moser Germany	9	77 1.4×	60 1.3×	30 0.9×	22 0.7×	29 1.3×	19	239
Gordon Kirkpatrick Canada	8	45 0.8×	31 0.7×	3 0.1×	13 0.4×	34 1.5×	13	232
Angela Loizidou Belgium	7	69 1.3×	29 0.6×	76 2.2×	4 0.1×	40 1.8×	13	182

Countries citing papers authored by Lisa M. Stempak

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Stempak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Stempak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Stempak more than expected).

Fields of papers citing papers by Lisa M. Stempak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Stempak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Stempak. The network helps show where Lisa M. Stempak may publish in the future.

Co-authorship network of co-authors of Lisa M. Stempak

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Stempak. A scholar is included among the top collaborators of Lisa M. Stempak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Stempak. Lisa M. Stempak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cherian, Sarah, et al.. (2024). Clinical Utility of Broad-Range PCR Testing and Impact on Outcomes in Adults with Suspected Infection. Antibiotics. 13(12). 1166–1166.

Cherian, Sarah, et al.. (2023). 986. Clinical Utility of 16S rRNA Sequencing and Impact on Outcomes in Adults with Suspected Infection. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Cummings, Linda C., et al.. (2022). Tailored Treatment Based on Helicobacter pylori Genetic Markers of Resistance Is Associated With Higher Eradication Success. The American Journal of Gastroenterology. 118(2). 360–363. 5 indexed citations

Windau, Anne, et al.. (2022). SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays. Diagnostic Microbiology and Infectious Disease. 104(4). 115803–115803. 13 indexed citations

Saade, Elie, et al.. (2022). Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system. SHILAP Revista de lepidopterología. 2(1). e47–e47. 1 indexed citations

Lim, Peter Paul, et al.. (2022). Determining the Clinical Utility of 16S rRNA Sequencing in the Management of Culture-Negative Pediatric Infections. Antibiotics. 11(2). 159–159. 6 indexed citations

Hubler, Zita, Xiao Song, Lisa M. Stempak, et al.. (2021). High-Throughput Adaptable SARS-CoV-2 Screening for Rapid Identification of Dominant and Emerging Regional Variants. American Journal of Clinical Pathology. 157(6). 927–935. 1 indexed citations

Bradbury, Richard S., Meredith Lane, Sukwan Handali, et al.. (2021). Parasitic Disease Surveillance, Mississippi, USA. Emerging infectious diseases. 27(8). 2201–2204. 8 indexed citations

Stempak, Lisa M., et al.. (2020). Development of a blood inventory management dashboard for inventory and usage monitoring in response to the COVID-19 pandemic. 60. 1 indexed citations

10.

Marquart, Mary E., et al.. (2018). Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis. PLoS ONE. 13(12). e0209849–e0209849. 10 indexed citations

11.

Stempak, Lisa M., Sherilynn Vogel, Sandra S. Richter, Robert Wyllie, & Gary W. Procop. (2018). Routine Broad-Range Fungal Polymerase Chain Reaction With DNA Sequencing in Patients With Suspected Mycoses Does Not Add Value and Is Not Cost-Effective. Archives of Pathology & Laboratory Medicine. 143(5). 634–638. 19 indexed citations

12.

Feghaly, Rana E. El, et al.. (2018). A quality improvement project: Decreasing blood culture contamination in a Children’s Hospital. PEDIATRICS. 142(1_MeetingAbstract). 353–353. 2 indexed citations

13.

Feghaly, Rana E. El, et al.. (2018). A Quality Improvement Initiative: Reducing Blood Culture Contamination in a Children’s Hospital. PEDIATRICS. 142(4). 20 indexed citations

14.

Hanna, Rabi, Aron Flagg, Lisa M. Stempak, et al.. (2016). Mycobacterium genavense‐induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature. Transplant Infectious Disease. 19(2). 10 indexed citations

15.

Hong, Hong, Wenbin Xiao, Lisa M. Stempak, Linda M. Sandhaus, & Robert W. Maitta. (2014). Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura. Transfusion. 55(4). 756–765. 21 indexed citations

16.

Stempak, Lisa M., et al.. (2013). Immature platelet fraction can help adjust therapy in refractory thrombotic microangiopathic hemolytic anemia cases. Transfusion and Apheresis Science. 49(3). 644–646. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact